Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
ASH 2019
Pharma
J&J's Darzalex cuts death risk by 40% in new myeloma patients
New "gold standard" data could further increase doctors' confidence in multiple myeloma med Darzalex, Johnson & Johnson says.
Carly Helfand
Dec 9, 2019 4:30pm
Takeda details Ninlaro's miss in AL amyloidosis
Dec 9, 2019 3:41am
Novartis trumpets Adakveo hospitalization data
Dec 8, 2019 6:00pm
BeiGene, eyeing Imbruvica in CLL, touts more early Brukinsa data
Dec 8, 2019 4:45pm
Gilead touts 'astounding' Yescarta survival results at 3 years
Dec 8, 2019 12:26pm
AbbVie, Roche pad case for fixed-duration Venclexta use in CLL
Dec 8, 2019 11:16am
